CIK 0000885590 · Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- Phone
- 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $258,894
- in 1 filing, $259K under 10b5-1 plans
Net −$258,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-11 | Eldessouky Sam EVP & Chief Financial Officer | Sale | −17,000 | $31.68 | $539K | 116,857 |
| 2021-06-02 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Option exercise | +60,345 | $14.38 | $868K | 227,103 |
| 2021-06-02 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Option exercise | +60,853 | $15.32 | $932K | 287,956 |
| 2021-06-02 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Sale | −121,198 | $31.83 | $3.9M | 166,758 |
| 2021-06-02 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Option exercise · Non-Qualified Stock Options (right to purchase) | −60,345 | 0 | ||
| 2021-06-02 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Option exercise · Non-Qualified Stock Options (right to purchase) | −60,853 | 0 | ||
| 2021-06-01 | Eldessouky Sam EVP & Chief Financial Officer | Grant or award | +33,673 | 133,857 | ||
| 2021-06-01 | Eldessouky Sam EVP & Chief Financial Officer | Grant or award · Non-Qualified Stock Options (right to purchase) | +122,427 | $32.03 | $3.9M | 122,427 |
| 2021-05-26 | WECHSLER AMY B Director | Sale | −11,037 | $31.79 | $351K | 98,325 |
| 2021-04-30 | Hale David Robert Director | Grant or award | +7,645 | 18,682 | ||
| 2021-04-30 | WECHSLER AMY B Director | Grant or award | +7,645 | 109,362 | ||
| 2021-04-30 | VON ESCHENBACH ANDREW C. Director | Grant or award | +7,645 | 37,247 | ||
| 2021-04-30 | Ross Thomas W. Sr. Director | Grant or award | +7,645 | 97,924 | ||
| 2021-04-30 | ROBERTSON RUSSEL C Director | Grant or award | +7,645 | 122,537 | ||
| 2021-04-30 | POWER ROBERT N Director | Grant or award | +7,645 | 101,424 | ||
| 2021-04-30 | Paulson John Director | Grant or award | +7,645 | 82,037 | ||
| 2021-04-30 | Miller Steven D Director | Grant or award | +7,645 | 8,637 | ||
| 2021-04-30 | KARABELAS ARGERIS N Director | Grant or award | +7,645 | 89,328 | ||
| 2021-04-30 | KAVANAGH SARAH B Director | Grant or award | +7,645 | 83,060 | ||
| 2021-04-30 | ICAHN BRETT Director | Grant or award | +7,645 | 8,515 |
Page 20 of 23 · 453 trades